University of Missouri - Kansas City, Kansas City, United States.
Stowers Institute for Medical Research, Kansas City, United States.
Elife. 2019 Jul 26;8:e49677. doi: 10.7554/eLife.49677.
Atxn7, a subunit of SAGA chromatin remodeling complex, is subject to polyglutamine expansion at the amino terminus, causing spinocerebellar ataxia type 7 (SCA7), a progressive retinal and neurodegenerative disease. Within SAGA, the Atxn7 amino terminus anchors Non-stop, a deubiquitinase, to the complex. To understand the scope of Atxn7-dependent regulation of Non-stop, substrates of the deubiquitinase were sought. This revealed Non-stop, dissociated from Atxn7, interacts with Arp2/3 and WAVE regulatory complexes (WRC), which control actin cytoskeleton assembly. There, Non-stop countered polyubiquitination and proteasomal degradation of WRC subunit SCAR. Dependent on conserved RC nteracting eceptor equences (WIRS), Non-stop augmentation increased protein levels, and directed subcellular localization, of SCAR, decreasing cell area and number of protrusions. , heterozygous mutation of SCAR did not significantly rescue knockdown of Atxn7, but heterozygous mutation of Atxn7 rescued haploinsufficiency of SCAR.
Atxn7 是 SAGA 染色质重塑复合物的一个亚基,其氨基末端易发生多聚谷氨酰胺扩展,导致脊髓小脑共济失调 7 型(SCA7),这是一种进行性视网膜和神经退行性疾病。在 SAGA 中,Atxn7 的氨基末端将 Non-stop(一种去泛素化酶)锚定在复合物上。为了了解 Atxn7 对 Non-stop 的调控范围,研究了去泛素化酶的底物。结果表明,与 Atxn7 分离的 Non-stop 与 Arp2/3 和 WAVE 调节复合物(WRC)相互作用,后者控制肌动蛋白细胞骨架的组装。在那里,Non-stop 拮抗了 WRC 亚基 SCAR 的多泛素化和蛋白酶体降解。依赖于保守的 RC 相互作用受体序列(WIRS),Non-stop 的增加提高了 SCAR 的蛋白水平,并指导其亚细胞定位,减少细胞面积和突起数量。然而,SCAR 的杂合突变并不能显著挽救 Atxn7 的敲低,但 SCAR 的 Atxn7 杂合突变挽救了其单倍不足。